1. Answer each one in a proper format
2. Include flowcharts where relevant
3. Reference the Apurv Shastri microbiology textbook
4. Compile everything into a downloadable PDF

---

MICROBIOLOGY PAPER I — COMPLETE ANSWERS

---

SECTION A: GENERAL MICROBIOLOGY

---

Q1. General Microbiology & Hospital Infection Control

• Hand hygiene (most important single measure)
• Standard precautions (gloves, masks, gowns)
• Isolation protocols (contact, droplet, airborne)
• Sterilization and disinfection of instruments
• Surveillance of healthcare-associated infections (HAIs)
• Antimicrobial stewardship

---

Q2. Bacterial Capsule — Composition, Function, Methods of Demonstration

• Mostly polysaccharides (e.g., Streptococcus pneumoniae, Klebsiella)
• Some are polypeptides (e.g., Bacillus anthracis — D-glutamic acid)

1. Anti-phagocytic — main virulence factor; resists engulfment by neutrophils
2. Antigenicity — used in vaccines (e.g., pneumococcal vaccine)
3. Adherence — helps bacteria attach to surfaces/biofilms
4. Protection from drying (desiccation)
5. Complement resistance — prevents opsonization

Bacterial Sample
      |
      ├──► India Ink Smear → Negative stain → Clear halo = Capsule
      |
      ├──► Quellung Rxn → Add antiserum → Capsule swells (Opaque) = Positive
      |
      ├──► Anthony's Stain → Crystal violet → Copper sulphate wash → Blue capsule
      |
      └──► Muir's Stain → Heat fix → Stain → Capsule = Red, Cell = Blue

---

Q3. Bacterial Pathogenesis

Exposure to Pathogen
        ↓
Colonization (Adherence to host cells via adhesins/pili/fimbriae)
        ↓
Invasion (Penetration of host tissues)
        ↓
Evasion of Host Defenses
  ├── Capsule (anti-phagocytic)
  ├── IgA protease
  ├── Intracellular survival
        ↓
Toxin Production
  ├── Exotoxins (proteins, heat-labile, e.g., cholera toxin)
  └── Endotoxins (LPS, gram-negative, heat-stable)
        ↓
Tissue Damage & Disease
        ↓
Outcome: Recovery / Chronic infection / Death

• Adhesins — pili, fimbriae (e.g., E. coli)
• Toxins — exotoxins, endotoxins
• Enzymes — coagulase, hyaluronidase, collagenase
• Capsule — anti-phagocytic
• Biofilm — protects from antibiotics and immune cells
• Antigenic variation — evades immune memory

---

Q4. Sterilization & Disinfection

• Sterilization: Complete destruction of ALL microorganisms including spores
• Disinfection: Destruction of most pathogenic microorganisms (NOT spores)
• Antisepsis: Disinfection applied to living tissue
• Asepsis: Prevention of entry of microorganisms

PHYSICAL STERILIZATION
        |
        ├── HEAT
        |     ├── DRY HEAT
        |     |     ├── Hot air oven: 160°C/1hr or 170°C/30 min
        |     |     ├── Incineration
        |     |     ├── Flaming
        |     |     └── Red heat
        |     |
        |     └── MOIST HEAT
        |           ├── Autoclave: 121°C/15 min/15 psi (GOLD STANDARD)
        |           ├── Pasteurization: 63°C/30 min (LTLT) or 72°C/15 sec (HTST)
        |           ├── Boiling: 100°C/10-30 min (NOT sterilization)
        |           └── Tyndallization: 100°C × 3 days (fractional)
        |
        ├── RADIATION
        |     ├── Ionizing: Gamma rays (cobalt-60) — disposables, catheters
        |     └── Non-ionizing: UV light — air, surfaces
        |
        └── FILTRATION
              ├── HEPA filters (air)
              └── Membrane filters: 0.22 µm (liquids, vaccines)

---

Q5. Role of Saliva in Transmission

SALIVA AS TRANSMISSION VEHICLE
            |
    ┌───────┴────────┐
Direct Contact     Droplets/Aerosols
    |                    |
Kissing, biting     Talking, coughing,
sharing utensils    sneezing
    |                    |
    └──────────┬─────────┘
               ↓
      Organisms Transmitted:
      ├── Viruses: EBV (mono), HSV-1, CMV, HIV (low risk), Rabies
      ├── Bacteria: Strep pyogenes, TB, Neisseria meningitidis
      └── Fungi: Candida albicans

---

Q6. CLABSI — Central Line-Associated Bloodstream Infection

• Coagulase-negative Staphylococci (most common)
• Staphylococcus aureus (including MRSA)
• Candida spp.
• Enterococcus
• Gram-negative rods (Klebsiella, Pseudomonas)

CVC Insertion
      ↓
Contamination Routes:
  ├── Extraluminal: Skin flora migrate along catheter exterior
  ├── Intraluminal: Hub/connector contamination
  ├── Hematogenous seeding
  └── Contaminated infusate
      ↓
Biofilm formation on catheter
      ↓
Bacteremia / Fungemia
      ↓
CLABSI

1. Hand hygiene before insertion
2. Maximal sterile barrier precautions
3. Chlorhexidine skin antisepsis
4. Optimal catheter site (subclavian preferred)
5. Daily review — remove catheter ASAP

---

Q7. Sporulation — Definition & Two Important Bacteria

• Resistant to heat, drying, radiation, chemicals
• NOT killed by boiling — require autoclaving
• Can remain viable for hundreds of years

Vegetative Cell (nutrient-rich environment)
        ↓ (Nutrient depletion / stress)
Axial filament formation
        ↓
Asymmetric cell division → Forespore engulfed
        ↓
Cortex formation + Coat protein deposition
        ↓
Mature Endospore formed
        ↓
Mother cell lysis → FREE SPORE released
        ↓
Germination (when conditions favorable)
        ↓
Vegetative cell resumes

1. Clostridium tetani — causes tetanus; terminal (drumstick) spore
2. Bacillus anthracis — causes anthrax; central spore

---

Q8. Anaerobic Culture — Definition & Methods

ANAEROBIC CULTURE METHODS
          |
    ┌─────┴──────────────────────┐
Physical methods           Chemical methods
    |                           |
    ├── Anaerobic jar           ├── Thioglycollate broth
    |   (McIntosh-Fildes jar)   |   (contains reducing agents)
    |   - H2 + CO2 generated    |
    |   - Palladium catalyst    ├── Pyrogallol-KOH method
    |   - O2 absorbed           |   (absorbs O2 chemically)
    |
    ├── Anaerobic cabinet/      └── Reducing agents in media
    |   Glove box                   (cysteine, Na-thioglycollate)
    |   (maintains <0.1% O2)
    |
    └── GasPak system
        (disposable H2+CO2
         generator sachet)

• Robertson's cooked meat medium
• Thioglycollate broth
• Blood agar (supplemented)

---

Q9. PCR (Polymerase Chain Reaction)

• Template DNA
• Primers (forward + reverse) — flank target sequence
• Taq polymerase (heat-stable DNA polymerase)
• dNTPs (deoxynucleotide triphosphates)
• MgCl₂ (cofactor)
• Buffer

Initial Denaturation (94-95°C, 2-5 min)
            ↓
    ┌── Cycle (30-40 cycles) ────────────────┐
    │                                         │
    │  DENATURATION (94°C, 30 sec)            │
    │  DNA double strand → Single strands     │
    │         ↓                               │
    │  ANNEALING (55-65°C, 30 sec)            │
    │  Primers bind to complementary DNA      │
    │         ↓                               │
    │  EXTENSION (72°C, 30-60 sec)            │
    │  Taq polymerase synthesizes new DNA     │
    └─────────────────────────────────────────┘
            ↓
Final Extension (72°C, 5-10 min)
            ↓
Hold (4°C)
            ↓
Gel Electrophoresis → Visualize bands

• RT-PCR (reverse transcriptase PCR) — for RNA viruses (HIV, SARS-CoV-2)
• Real-time PCR (qPCR) — quantitative
• Multiplex PCR — multiple targets simultaneously
• Nested PCR — increased sensitivity

---

Q10. High-Level Disinfectants

HIGH-LEVEL DISINFECTION FLOWCHART
          ↓
Clean instrument thoroughly (remove debris)
          ↓
Immerse in HLD agent (e.g., 2% Glutaraldehyde)
          ↓
Adequate contact time (20-30 min)
          ↓
Rinse with sterile water
          ↓
Dry and store in sterile container
          ↓
Ready for use on SEMI-CRITICAL items
(items contacting mucous membranes)

---

Q11. Antimicrobial Stewardship

• Optimize antibiotic selection, dose, duration
• Reduce Clostridioides difficile infections
• Reduce antibiotic resistance
• Reduce adverse drug reactions

ANTIMICROBIAL STEWARDSHIP PROGRAM
              |
    ┌─────────┴──────────────┐
Prospective audit        Formulary restriction
& feedback               & prior authorization
              |
    ┌─────────┴──────────────┐
De-escalation            IV to oral switch
(narrow spectrum when    (when patient improves)
culture results return)
              |
    ┌─────────┴──────────────┐
Dose optimization        Duration guidelines
(PK/PD principles)       (shorter courses preferred)

---

Q12. Healthcare-Associated Infections (HAIs)

HOST FACTORS              HEALTHCARE FACTORS
- Immunocompromised    ←→  - Indwelling devices
- Elderly                  - Invasive procedures
- Diabetes                 - Prolonged hospitalization
- Malnutrition             - Broad-spectrum antibiotics
- Chronic disease          - Poor hand hygiene

• Hand hygiene (WHO 5 moments)
• Standard + transmission-based precautions
• Device care bundles (CLABSI, CAUTI bundles)
• Surveillance and feedback
• Antimicrobial stewardship

---

Q13. Needle-Stick Injury

• HIV (transmission risk ~0.3%)
• Hepatitis B virus (transmission risk 6-30%)
• Hepatitis C virus (transmission risk 1.8%)

NEEDLE-STICK INJURY
        ↓
IMMEDIATE (within seconds):
  - Wash wound with soap & water for 5 min
  - Do NOT suck or squeeze wound
  - Allow to bleed freely
        ↓
REPORT immediately to supervisor/occupational health
        ↓
RISK ASSESSMENT of source patient:
  - HIV status, HBV, HCV status
  - If unknown → test source patient
        ↓
BASELINE TESTING of injured HCW:
  - HIV, HBsAg, Anti-HCV, Anti-HBs
        ↓
POST-EXPOSURE PROPHYLAXIS (PEP):
  ├── HIV: Start PEP within 2 hours (max 72 hrs)
  |   - TDF + FTC + Integrase inhibitor × 28 days
  ├── HBV: HBIG + HBV vaccine (if unvaccinated)
  └── HCV: No PEP; monitor & treat if infected
        ↓
FOLLOW-UP testing at 6 weeks, 3 months, 6 months

---

Q14. Clostridium difficile and HAI

Antibiotic use (especially clindamycin, fluoroquinolones, cephalosporins)
        ↓
Disruption of normal gut flora
        ↓
C. difficile (from environment/spores) colonizes colon
        ↓
Produces Toxin A (enterotoxin) + Toxin B (cytotoxin)
        ↓
Mucosal damage → Inflammation → Pseudomembranous colitis
        ↓
Watery/bloody diarrhea, fever, abdominal pain
        ↓
Severe: Toxic megacolon, perforation, death

• Stool PCR for C. difficile toxin genes (most sensitive)
• Enzyme immunoassay (EIA) for toxins A+B
• GDH antigen detection
• Culture (anaerobic, CCFA medium)

• Stop offending antibiotic
• Oral Vancomycin or Fidaxomicin (first-line)
• Metronidazole (mild cases)
• Fecal microbiota transplant (recurrent CDI)

• Contact precautions (gown + gloves)
• Hand hygiene with soap and water (alcohol NOT effective against spores)
• Environmental cleaning with bleach (hypochlorite)
• Antibiotic stewardship

---

Q15. Sterilization — Autoclave

• Temperature: 121°C
• Pressure: 15 psi (103 kPa)
• Time: 15-20 minutes
• (For porous loads: 134°C / 30 psi / 3-4 min)

• Cylindrical chamber
• Steam inlet valve
• Pressure gauge
• Safety valve
• Temperature gauge
• Air exhaust valve

Water heated → Steam generated
        ↓
Air removed (downward displacement or vacuum)
        ↓
Pressure builds → Temperature rises to 121°C
        ↓
Steam penetrates materials → moist heat kills microbes
  (Protein denaturation + Coagulation)
        ↓
Holding time (15 min)
        ↓
Steam exhaust → Cooling
        ↓
Sterile items removed

• Biological indicator: Geobacillus stearothermophilus spores (most reliable)
• Chemical indicator: Bowie-Dick test, autoclave tape
• Physical: Temperature/pressure/time records

---

Q16. Phases of Bacterial Growth

BACTERIAL GROWTH CURVE
Number of Bacteria (log scale)
        |              ___________
        |             /           \
        |            /             \
        |           /               \
        |          /                 \______
        |_________/
        |
        +------+------+------+------+---> Time
         Lag   Log  Stationary  Decline
         Phase Phase  Phase      Phase

---

Q17. Koch's Postulates

KOCH'S POSTULATES
         |
         ↓
1. The microorganism must be found in ALL cases of the disease
   (in diseased host, not in healthy)
         |
         ↓
2. The organism must be ISOLATED from diseased host
   and grown in PURE CULTURE
         |
         ↓
3. The pure culture must REPRODUCE THE DISEASE
   when inoculated into a healthy susceptible host
         |
         ↓
4. The organism must be RE-ISOLATED from the
   experimentally diseased host and shown to be
   IDENTICAL to the original organism

• Asymptomatic carriers (Vibrio cholerae, H. pylori)
• Cannot culture all organisms (M. leprae, viruses)
• Some diseases caused by multiple organisms
• Ethical issues with human experiments

---

Q18. Mechanism of Drug Resistance

1. Intrinsic/Natural resistance — inherent to bacterial species
2. Acquired resistance — develops through mutation or gene transfer

MECHANISMS OF ANTIBIOTIC RESISTANCE
              |
    ┌─────────┼──────────────────┐
    ↓         ↓                  ↓
Enzymatic    Altered target    Reduced drug
Inactivation site              accumulation
    |             |                  |
β-lactamase   PBP mutations    ├── Efflux pumps
Aminoglycoside (MRSA: PBP2a)   |   (drug pumped out)
 modifying     Ribosome         └── Porin loss
 enzymes       mutations            (reduced entry)
 Chloramphenicol (macrolides,
 acetyltransferase  aminoglycosides)

• Conjugation — plasmid transfer (most common for resistance)
• Transformation — uptake of naked DNA
• Transduction — bacteriophage-mediated transfer
• Transposons — "jumping genes" move resistance between plasmids

• MRSA → altered PBP2a (mecA gene)
• ESBL-producing E. coli/Klebsiella → β-lactamase
• VRE → altered cell wall precursor (vanA/vanB genes)

---

Q19. Biofilm

Free-floating (planktonic) bacteria
        ↓
Initial reversible attachment to surface
        ↓
Irreversible attachment (adhesins, fimbriae)
        ↓
Microcolony formation
        ↓
EPS matrix production (polysaccharides, proteins, DNA)
        ↓
Mature biofilm (3D structure with water channels)
        ↓
Dispersal: Bacteria shed → colonize new surfaces

• 1000× more resistant to antibiotics than planktonic bacteria
• Resistant to host immune responses
• Common on: prosthetic valves, catheters, joint implants, dental plaque

• S. epidermidis — IV catheters
• P. aeruginosa — lungs in CF patients
• Streptococcus mutans — dental caries

---

Q20. Antimicrobial Susceptibility Testing

Bacteria swabbed uniformly on Mueller-Hinton agar
        ↓
Antibiotic-impregnated discs placed on plate
        ↓
Incubate 18-24 hrs at 37°C
        ↓
Measure Zone of Inhibition (in mm)
        ↓
Compare to CLSI/EUCAST breakpoints
        ↓
Report: Susceptible (S) / Intermediate (I) / Resistant (R)

• Minimum Inhibitory Concentration (MIC) = lowest concentration of antibiotic that inhibits visible growth
• Minimum Bactericidal Concentration (MBC) = lowest concentration that kills 99.9% bacteria

• Plastic strip with antibiotic gradient → gives precise MIC value

---

Q21. Inclusion Bodies

---

Q22. Serodiagnosis of Parasitic Infections

• Cannot distinguish active from past infection (IgG remains)
• Cross-reactions between parasites
• IgM suggests recent/active infection

---

Q23. Antigenic Shift & Antigenic Drift

ANTIGENIC DRIFT:
Original HA → mutation → slightly altered HA
(gradual, minor changes → epidemics)

ANTIGENIC SHIFT:
Human flu virus + Animal flu virus
co-infect same cell
        ↓
Gene segments MIX (reassortment)
        ↓
New virus with novel HA+NA combination
        ↓
No existing immunity in population
        ↓
PANDEMIC

---

Q24. Fungal Infections

FUNGAL INFECTIONS
        |
        ├── SUPERFICIAL (skin/hair/nail)
        |     ├── Dermatophytosis (Tinea) — Trichophyton, Microsporum
        |     ├── Tinea versicolor — Malassezia furfur
        |     └── Piedra (black/white)
        |
        ├── SUBCUTANEOUS
        |     ├── Mycetoma (Madura foot)
        |     ├── Sporotrichosis — Sporothrix schenckii
        |     └── Chromoblastomycosis
        |
        └── SYSTEMIC / DEEP
              ├── Opportunistic (immunocompromised)
              |   ├── Candidiasis — Candida albicans
              |   ├── Aspergillosis — Aspergillus fumigatus
              |   ├── Cryptococcosis — Cryptococcus neoformans
              |   └── Mucormycosis — Rhizopus, Mucor
              └── Primary (healthy host, endemic)
                  ├── Histoplasmosis — Histoplasma capsulatum
                  ├── Blastomycosis — Blastomyces dermatitidis
                  └── Coccidioidomycosis — Coccidioides immitis

---

SECTION B: IMMUNITY

---

Q1 & Q9. Types of Hypersensitivity (Gell & Coombs Classification)

First Exposure to Allergen
        ↓
B cells → IgE production → IgE binds to mast cells/basophils
        ↓
Second Exposure: Allergen binds IgE on mast cells
        ↓
CROSS-LINKING of IgE → Mast cell degranulation
        ↓
Release: Histamine, Leukotrienes, Prostaglandins
        ↓
Vasodilation, Bronchoconstriction, Urticaria
        ↓
ANAPHYLAXIS (severe systemic reaction)

---

Q2. Components of Innate Immunity

INNATE IMMUNITY
        |
        ├── PHYSICAL BARRIERS
        |     ├── Skin (intact, keratin layer)
        |     ├── Mucus membranes
        |     ├── Cilia (respiratory tract)
        |     └── Tears, saliva, urine flow
        |
        ├── CHEMICAL BARRIERS
        |     ├── Lysozyme (tears, saliva)
        |     ├── Gastric acid (pH 1-2)
        |     ├── Defensins (skin, gut)
        |     └── Sebaceous fatty acids
        |
        ├── CELLULAR COMPONENTS
        |     ├── Neutrophils (phagocytosis)
        |     ├── Macrophages (phagocytosis + APC)
        |     ├── NK cells (kill virus-infected cells)
        |     ├── Dendritic cells (APC)
        |     └── Mast cells, Eosinophils, Basophils
        |
        └── SOLUBLE MEDIATORS
              ├── Complement system (C3a, C5a, MAC)
              ├── Interferons (IFN-α, IFN-β — antiviral)
              ├── Cytokines (IL-1, IL-6, TNF-α)
              └── Acute phase proteins (CRP, fibrinogen)

• Toll-like receptors (TLRs) recognize PAMPs (pathogen-associated molecular patterns)

---

Q3. National Immunization Schedule & Applications

---

Q4. Clonal Selection Hypothesis

CLONAL SELECTION THEORY
        |
Pre-existing pool of lymphocytes
(each with unique antigen receptor)
        ↓
Antigen enters body
        ↓
Antigen binds to the SPECIFIC lymphocyte
whose receptor matches (clonal selection)
        ↓
Selected clone undergoes PROLIFERATION
(clonal expansion)
        ↓
Differentiates into:
  ├── Effector cells (immediate response)
  |   ├── Plasma cells → antibodies (B cells)
  |   └── Cytotoxic T cells (T cells)
  └── Memory cells (long-lived; faster response on re-exposure)
        ↓
SECONDARY RESPONSE (faster, stronger)
when same antigen encountered again

• Explains specificity, memory, and self-tolerance
• Forbidden clones (self-reactive) eliminated in thymus/bone marrow
• Failure of deletion → Autoimmune disease

---

Q5. Cell-Mediated Immunity (CMI) vs Antibody-Mediated Immunity (AMI)

---

Q6. Immunoglobulins

• Fab fragment = antigen binding
• Fc fragment = complement binding, placental transfer, macrophage binding

---

Q7. Complement System

COMPLEMENT ACTIVATION PATHWAYS

Classical Pathway          Lectin Pathway         Alternative Pathway
(IgM/IgG + Ag complex)   (Mannose-binding       (Direct pathogen
        ↓                  lectin + mannan)        surface activation)
    C1q, C1r, C1s              ↓                        ↓
        ↓               MASP-1, MASP-2                   ↓
        └──────────────────────┴────────────────────────┘
                               ↓
                    C3 CONVERTASE (C4b2a or C3bBb)
                               ↓
                    C3 → C3a + C3b
                               ↓
                   C5 CONVERTASE
                               ↓
                    C5 → C5a + C5b
                               ↓
               C5b + C6,C7,C8,C9 → MAC
               (Membrane Attack Complex)
                               ↓
                      BACTERIAL LYSIS

• C3b → Opsonization (enhances phagocytosis)
• C3a, C5a → Anaphylatoxins (mast cell degranulation, chemotaxis)
• MAC (C5b-9) → Lysis of bacteria

---

Q8 & Q11. Active vs Passive Immunity

---

Q10. Innate vs Acquired Immunity

---

Q12. Herd Immunity

• HIT = 1 - (1/R₀), where R₀ = basic reproduction number

LOW VACCINATION COVERAGE:        HIGH VACCINATION COVERAGE:
Infected → spreads widely         Infected → chain broken
😷→😐→😐→😐→😐                 😷→💉→💉→💉→(stops)
Epidemic occurs                   Vulnerable protected

---

Q13. Acquired Immunity

• Humoral: B cell → plasma cell → antibodies (IgM, IgG, IgA, IgE, IgD)
• Cell-mediated: T cells → CD4+ helper, CD8+ cytotoxic, regulatory T cells

---

Q14. ELISA (Enzyme-Linked Immunosorbent Assay)

ELISA TYPES

1. DIRECT ELISA:
Antigen coated on well → Enzyme-labeled antibody added → Substrate → Color

2. INDIRECT ELISA (most common for serology):
Antigen coated → Patient serum (primary Ab) → Enzyme-labeled secondary Ab → Substrate → Color

3. SANDWICH ELISA (for antigen detection):
Capture Ab coated → Antigen → Detection Ab (enzyme-labeled) → Substrate → Color

4. COMPETITIVE ELISA:
Antigen + labeled antigen compete for limited antibody → LESS color = MORE antigen

• HIV diagnosis (screening test)
• Hepatitis B (HBsAg, Anti-HBs, HBeAg)
• TORCH infections (Toxoplasma, Rubella, CMV, HSV)
• Dengue (NS1 antigen, IgM/IgG)
• COVID-19 antibody testing

---

SECTION C: UNIT II (Bacteriology)

---

Q1. Cholera

• Gram-negative, comma-shaped (curved) rod
• Single polar flagellum (monotrichous)
• Highly motile — "shooting star" motility on dark ground microscopy
• Non-spore forming, non-capsulated
• Grows in alkaline media (pH 8.6)

SPECIMEN: Rice-watery stool
        ↓
Alkaline Peptone Water (APW) pH 8.6 — ENRICHMENT
(Incubate 6-8 hrs)
        ↓
Subculture onto TCBS agar (Thiosulfate Citrate Bile Salts Sucrose)
        ↓
Yellow colonies (sucrose fermenters) on TCBS
        ↓
Gelatin stab: "Inverted fir-tree" pattern
        ↓
Confirmatory: Agglutination with O1 antisera
(Ogawa, Inaba, Hikojima subtypes)

• A subunit (active): ADP-ribosylates Gs protein → permanent activation of adenylate cyclase → ↑↑↑ cAMP
• B subunit (binding): binds GM1 ganglioside on intestinal epithelial cells
• Effect: Massive secretion of Cl⁻ and water → Rice-water diarrhea (up to 20 L/day)

1. Dark-ground microscopy (shooting star motility)
2. Culture on TCBS — yellow colonies
3. Agglutination with O1/O139 antiserum
4. String test (positive — V. cholerae forms string with 0.5% sodium deoxycholate)
5. Oxidase positive
6. Cholera red reaction (positive)

• Feco-oral route; contaminated water/food
• 7 pandemics; current (7th) caused by El Tor biotype
• Short incubation: 6 hours - 5 days
• High infective dose (~10⁸ organisms needed)

• Safe water and sanitation
• Oral cholera vaccine (OCV): Dukoral (killed + CTB), Shanchol
• ORT (oral rehydration therapy) for treatment
• IV fluids for severe cases + Tetracycline/Doxycycline

---

Q2. Listeria — Laboratory Diagnosis

• Tumbling motility at 25°C (umbrella-shaped motility in semisolid media)
• Cold enrichment growth at 4°C (refrigerator temperature — unique)
• β-hemolysis on blood agar
• Catalase positive, oxidase negative
• Produces CAMP factor (enhances S. aureus hemolysis)

SPECIMEN: Blood, CSF, amniotic fluid, meconium
        ↓
GRAM STAIN: Short Gram-positive rods
(may be mistaken for diphtheroids)
        ↓
CULTURE:
  ├── Blood agar: Small grey colonies with β-hemolysis
  ├── PALCAM/Oxford agar (selective): Grey-green colonies with black halo
  └── Cold enrichment (4°C) for food samples
        ↓
MOTILITY TEST: Tumbling motility at 25°C
(umbrella pattern in semisolid agar)
        ↓
BIOCHEMICAL:
  - Catalase +, Oxidase -
  - Esculin hydrolysis +
  - CAMP test + (with S. aureus)
        ↓
SEROTYPING: Type 4b (most common in epidemics)
MOLECULAR: PCR (hlyA gene for listeriolysin O)

---

Q3. Bacillus cereus — Food Poisoning

Contaminated rice/meat cooked
        ↓
Left at room temperature (spores survive cooking)
        ↓
Spores germinate → vegetative cells multiply
        ↓
Toxin produced (cereulide in rice)
        ↓
Consumption → 1-6 hrs → Vomiting (Emetic type)
OR
8-16 hrs → Diarrhea (Diarrheal type)
        ↓
Self-limiting (24-48 hrs); supportive treatment

---

Q4. Campylobacter — Laboratory Diagnosis

• Gram-negative, S-shaped/spiral/seagull-shaped curved rod
• Single polar flagellum (darting/corkscrew motility)
• Microaerophilic (5% O₂, 10% CO₂)
• Thermophilic — grows at 42°C (used for selective culture)
• Oxidase positive, catalase positive

SPECIMEN: Fresh stool (within 2 hrs; Cary-Blair transport medium)
        ↓
DIRECT MICROSCOPY:
  - Gram stain: Thin curved Gram-negative rods
  - Dark field: Darting corkscrew motility
        ↓
CULTURE:
  Campy-BAP (Blood Agar with antibiotics):
    - Vancomycin, Trimethoprim, Polymyxin B, Amphotericin B, Cephalothin
  OR Skirrow's medium
  CONDITIONS: Microaerophilic (5% O₂, 10% CO₂), 42°C, 48-72 hrs
        ↓
COLONIES: Grey, flat, spreading, "running water" appearance
        ↓
BIOCHEMICAL:
  - Oxidase +, Catalase +
  - Hippurate hydrolysis + (C. jejuni only)
  - Nalidixic acid sensitive (C. jejuni), resistant (C. coli)
        ↓
SEROLOGY: Passive hemagglutination
MOLECULAR: PCR (most sensitive)

---

Q5. Vibrio vulnificus

1. Gastroenteritis — after eating raw shellfish
2. Primary septicemia — especially in liver disease/immunocompromised (high fatality >50%)
3. Wound infection — after exposure to seawater or seafood handling

• Capsule (anti-phagocytic)
• Siderophore (iron acquisition — especially dangerous in iron-overload states)
• Cytolysin
• Collagenase, protease

• Gastroenteritis: diarrhea, vomiting
• Septicemia: fever, hypotension, secondary skin lesions (bullous/necrotic)
• Wound infection: cellulitis → necrotizing fasciitis

• Culture on TCBS agar: Blue-green colonies (does NOT ferment sucrose, unlike V. cholerae)
• Halophilic: grows in 3% NaCl
• Oxidase positive

---

Q6. Intestinal Anthrax

Ingestion of spores in contaminated meat
        ↓
Spores germinate in intestinal mucosa
(ileum/cecum most affected)
        ↓
Vegetative bacilli produce toxins:
  - Protective antigen (PA)
  - Edema factor (EF) → PA+EF = Edema toxin → massive edema
  - Lethal factor (LF) → PA+LF = Lethal toxin → cell death, hemorrhage
        ↓
Ulceration of intestinal mucosa → bloody ascites
        ↓
Bacteremia → Septicemia → Meningitis
        ↓
High mortality (25-60%) if untreated

• Prodrome: nausea, vomiting, fever
• Severe: bloody diarrhea, abdominal pain, ascites
• Toxemia, septicemia

• Blood culture (large Gram-positive rods in chains — "bamboo-cane" appearance)
• Medusa head colonies on blood agar
• Non-hemolytic (unlike other Bacillus species)
• Capsule demonstration (India ink / M'Fadyean stain)
• PCR for pXO1 (toxin genes) and pXO2 (capsule genes) plasmids

---

---

• Bacterial capsule, sporulation, pathogenesis, sterilization, PCR, biofilm, drug resistance, Koch's postulates, bacterial growth phases, inclusion bodies, antigenic shift/drift, fungal infections, CLABSI, HAI, needle-stick injury, C. difficile, autoclave, antimicrobial stewardship, AST, anaerobic culture, serodiagnosis, saliva transmission

• Hypersensitivity types I-IV, innate immunity components, national immunization schedule, clonal selection theory, CMI vs AMI, immunoglobulins, complement system, active vs passive immunity, innate vs acquired immunity, herd immunity, ELISA

• Cholera (full: morphology, culture, toxin, lab diagnosis, epidemiology, prophylaxis)
• Listeria lab diagnosis
• Bacillus cereus food poisoning
• Campylobacter lab diagnosis
• Vibrio vulnificus
• Intestinal anthrax